Pharmacokinetic study

CY Chisato M. Yamazaki
AY Aiko Yamaguchi
YA Yasuaki Anami
WX Wei Xiong
YO Yoshihiro Otani
JL Jangsoon Lee
NU Naoto T. Ueno
NZ Ningyan Zhang
ZA Zhiqiang An
KT Kyoji Tsuchikama
request Request a Protocol
ask Ask a question
Favorite

Female, 6–8 weeks old CD-1® IGS mice (Charles River Laboratories, Strain Code: 022) were randomly assigned to each group (n = 3 for MMAE DAR 4 ADC; n = 4 for other groups) and were administered intravenously with the unmodified N297A anti-HER2 mAb or each ADC at a dose of 3 mg kg−1. Blood samples (5 µL) were collected from each animal via the tail vein at each time point (15 min, 5 h, 1 day, 2 days, 4 days, 9 days, and 14 days) and diluted in 495 µL of 5 mM EDTA in PBS. After removal of cells by centrifugation (10 min at 9400 × g at 4 °C), plasma samples were stored at −80 °C until used for subsequent sandwich ELISA. For determination of the total antibody concentration (both conjugated and unconjugated), a high-binding 96-well plate (Corning) was coated with goat anti-human IgG Fc antibody (500 ng per well) diluted in 100 mM sodium carbonate buffer (pH 9.4). After overnight incubation at 4 °C, the plate was blocked with 100 µL of 2% BSA in PBS containing 0.05% Tween 20 (PBS-T) at room temperature for 1 h. Subsequently, the solution was removed and each diluted plasma sample (100 µL in PBS-T containing 1% BSA) was added to each well, and the plate was incubated at room temperature for 2 h. After each well was washed three times with PBS-T, 100 µL of goat anti-human IgG Fab-HRP conjugate (1 : 5000) was added. After being incubated at room temperature for 1 h, the plate was washed and color development was performed as described above (see the section of “Cell-based ELISA assay”). For determination of ADC concentration (conjugated only), assays were performed in the same manner using human HER2 (100 ng per well, ACROBiosystems) for plate coating, mouse anti-MMAE/F antibody (1 : 5000), and goat anti-mouse IgG-HRP conjugate (1 : 10,000) as secondary and tertiary detection antibodies, respectively. All assays were performed in triplicate. Concentrations were calculated based on a standard curve. Half-life of each conjugate at the elimination phase (t1/2β) was estimated using methods for non-compartmental analysis54,55. PKSolver (a freely available menu-driven add-in program for Microsoft Excel)54,55 was used to calculate t1/2β and area under the curve (AUC0–∞, h × μg mL−1).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A